BAVACHININ A (cas 19879-30-2)nalogues as agonists of pan-peroxisome proliferator-activated receptors

Add time:09/28/2019    Source:infona.pl

Peroxisome proliferator-activated receptors (PPARs) agonists contribute to the regulation of glucose, lipid, and cholesterol metabolism and have emerged as key targets to treat metabolic syndrome. In our previous study, the natural compound bavachinin was found to have pan-PPAR agonist activity. In this study, five isoflavones, three isoflavanones, and five scaffold-hopping analogues of bavachinin were designed, synthesised, and evaluated through reporter gene assays for pan-PPAR agonist activity. The analogue 2-(4-hydroxyphenyl)-6-isopentenyl-7-methoxy-2,3-dihydroquinolin-4(1H)-one (21) was identified as a pan-PPAR agonist, exhibiting substantially higher PPAR α/β agonist activity and equal PPAR-γ agonist activity than does bavachinin.

We also recommend Trading Suppliers and Manufacturers of BAVACHININ A (cas 19879-30-2). Pls Click Website Link as below: cas 19879-30-2 suppliers

Prev:Biotransformation of bavachinin by three fungal cell cultures
Next:Development of a fully automated on-line solid phase extraction and high-performance liquid chromatography with diode array detection method for the pharmacokinetic evaluation of bavachinin: A study on absolute bioavailability and dose proportionality)